| Names | |
|---|---|
| Preferred IUPAC name | Disodium [(2R,3S,4R,5R)-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| Other names | E631 Disodium inosinate Disodium 5’-inosinate Disodium inosine-5’-monophosphate Disodium 5’-IMP IMP, disodium salt |
| Pronunciation | /daɪˈsoʊdiəm faɪv aɪˈnoʊsin/ |
| Identifiers | |
| CAS Number | 4691-65-0 |
| Beilstein Reference | 357933 |
| ChEBI | CHEBI:32508 |
| ChEMBL | CHEMBL1209677 |
| ChemSpider | 188054 |
| DrugBank | DB01765 |
| ECHA InfoCard | ECHA InfoCard: 100.032.490 |
| EC Number | E631 |
| Gmelin Reference | 130131 |
| KEGG | C00794 |
| MeSH | D019284 |
| PubChem CID | 441355 |
| RTECS number | NJ5825000 |
| UNII | F8VZ92KEXC |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID30896853 |
| Properties | |
| Chemical formula | C10H11N4Na2O8P |
| Molar mass | 370.15 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.89 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -3.7 |
| Acidity (pKa) | 1.5 |
| Basicity (pKb) | 11.2 |
| Magnetic susceptibility (χ) | -54×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.613 |
| Dipole moment | 6.1 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 302.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1922.7 kJ/mol |
| Pharmacology | |
| ATC code | A16AX14 |
| Hazards | |
| Main hazards | May cause respiratory irritation. |
| GHS labelling | GHS07 |
| Pictograms | GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | Not a hazardous substance or mixture. |
| Precautionary statements | Precautionary statements: P261, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 1-0-0 |
| Lethal dose or concentration | Lethal dose or concentration: LD₅₀ (oral, rat): > 10,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): > 5000 mg/kg (rat, oral) |
| NIOSH | Not listed |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 0.05 mg/kg bw |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds | Inosine Disodium guanosine monophosphate Disodium uridine monophosphate Disodium adenosine monophosphate Disodium cytidine monophosphate |
| Property | Description |
|---|---|
| Product Name | Disodium 5'-Inosine |
| IUPAC Name | Disodium [(2R,3S,4R,5R)-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| Chemical Formula | C10H11N4Na2O8P |
| Synonyms & Trade Names |
Disodium inosinate Disodium inosinic acid E631 Inosine-5'-monophosphate disodium salt IMP 5'-disodium salt |
| HS Code & Customs Classification | Typical classification: 2934.99 (Other nucleic acids and their salts; other heterocyclic compounds) |
| CAS Number | 4691-65-0 |
Disodium 5'-inosine production in industrial environments hinges on precise enzymatic or chemical phosphorization of inosine, followed by controlled neutralization to the disodium salt. Choice of starting inosine, catalyst system, and degree of phosphate conversion influence both yield and impurity spectrum.
Raw material sourcing remains critical: pharmaceutical or food grades require verified inosine purity, free from nucleoside analogs or degradation products. Process selection depends on application. Food-grade lines prioritize enzymatic selectivity to minimize side products, while technical-grade lines often allow broader impurity profiles where functional use in fermentation or animal feeds does not require stringent taste or purity thresholds.
Purification is grade-driven. Food and pharmaceutical grades generally involve multi-step crystallization, activated carbon decolorization, and ion-exchange polishing to remove colored impurities, mono- and polyphosphates, or alkali contaminants. Release criteria include chromatographic profile, sodium content, moisture, and residual inorganic phosphate—all values tailored and routinely reviewed as per contract specifications or regional regulations.
Batch consistency management integrates in-process controls such as pH monitoring, phosphate assay, and end-point sodium titration. High batch repeatability supports downstream users—especially those in formulation or food blending—where both chemical uniformity and particle-size stability affect solubility and dosage accuracy. Environmental factors, including residual moisture and particle caking, must be tightly controlled for long-term storage and international transit.
Typical values for physical and chemical properties, including assay, loss on drying, and ash content, depend on product grade and final use. Detailed specifications can be defined according to the application and regulatory requirements relevant to the destination market. All release standards reflect ongoing internal quality control data supplemented by customer or third-party laboratory verification for critical markets.
Disodium 5'-inosine typically appears as a white to off-white crystalline powder in industrial production. The particle size, moisture content, and granulation are tailored to specific customer process requirements. Some grades may display minor differences in hue and granule morphology due to variations in crystallization and drying procedures. Melting point observations and odor are not normally regarded as critical quality attributes, but process deviations can result in off-color or detectable odor, which prompt batch hold and investigation.
Key physical constants such as density and melting point depend on grade specification and production lot history. Melting and decomposition can overlap, especially under elevated temperatures relevant to downstream thermal processing. Disodium 5'-inosine does not display a true boiling point under typical atmospheric conditions, and flash point considerations rarely apply due to its inherent low volatility and high water solubility.
Stability depends on moisture and temperature exposure during storage. Under anhydrous, controlled conditions, negligible degradation occurs. Prolonged exposure to high humidity or elevated process temperatures can cause hydrolysis or promote Maillard-type browning, especially in blends and food-use applications. Product is non-reactive with typical food additives but may participate in ionic exchange or salt crystallization with incompatible cationic ingredients.
Solubility in water permits straightforward solution preparation, but dissolution rate varies according to particle size distribution and agglomeration state. Rapid solution prep benefits from agitation and gradual addition to minimize localized supersaturation. Undissolved residues or turbidity signal either incomplete dissolution or the presence of process-related insolubles—both treated as quality deviations in production settings. Solubility is application-specific: food, biotech, and pharmaceutical solutions must address additional purity, microbial, and handling guidelines.
Specification requirements, including appearance, pH, assay, and impurity thresholds, are determined by customer segment and downstream use. Food, pharma, and biotech applications require progressively tighter controls on purity, moisture, heavy metals, and microbiological load. Actual specification values reflect commercial agreements or pharmacopeial/food additive demands.
Major impurities typically include related nucleotides, inorganic salts, and process residues such as sodium chloride or minor organic byproducts. Impurity profile depends heavily on the synthetic route and purification robustness. Each batch undergoes targeted analysis for inorganic ions and organic impurities, with critical limits set by intended use (e.g., infant nutrition, pharmaceutical, general food). Process audit trails track any excursions and drive corrective action.
Test methodologies anchor against validated in-house procedures, or, where applicable, comply with regional or international pharmacopoeia and food additive standards. Methods include HPLC for main component and impurities, loss on drying for water content, and ICP-OES or AAS for elemental impurities. Control charts monitor intra-batch and inter-batch consistency, with all data feeding into final batch release criteria. Customer audits frequently review test method robustness as part of ongoing supplier qualification.
Raw material selection focuses on cost, purification ease, and regulatory traceability. Sourcing adenosine or inosine precursors requires proven vendor histories to ensure impurity tracebacks and compliance with food or pharma grade requirements. Sodium carbonate and sodium hydroxide, when used, require secondary testing to exclude heavy metal and organic contaminant inflow.
Production commonly follows enzymatic or chemical phosphorylation of inosine, with route selection tied directly to regulatory and impurity profile requirements. Enzymatic methods offer fewer side products and greater selectivity but incur higher enzyme cost and periodic batch yields variance. Chemical synthesis remains viable for technical or food-grade product, balancing cost with additional control measures for unreacted intermediates.
Critical process control points span pH adjustment, reaction temperature, enzyme/activity monitoring, and downstream crystallization or filtration. Purification involves repeated recrystallization or advanced chromatographic separation, especially for grades requiring tight nucleotide ratio or minimal process byproduct levels. Water quality management and in-process microbial control underpin all pharmaceutical and infant-grade runs.
Quality control coordinates sampling through defined lot stages, including raw material intake, intermediates, and finished material. Each control point checks compliance to specification tables, with out-of-spec findings triggering full deviation analysis. Batch release aligns with specification sheet, customer-specific requirements, and internal trend data. Certificates of Analysis detail both routine and special-release parameters, supporting traceability and regulatory compliance.
Disodium 5'-inosine, as a nucleotide salt, remains primarily stable under neutral aqueous conditions. Under controlled acidic or basic conditions, partial hydrolysis or conversion to related nucleotides occurs, a behavior sometimes leveraged in biotech or flavor modification. Strong oxidizers can degrade the purine ring, yielding byproducts outside standard food or pharma acceptance.
Application-specific chemical transformations favor aqueous, neutral to slightly alkaline conditions to retain product integrity. No typical use for catalyst-driven transformation at commercial scale; temperature control is critical, as heat-labile degradation products appear above defined thresholds depending on grade and purity targets.
Derivative synthesis provides access to other nucleotides or nucleotide-based enzymes, subject to controlled reaction setup. The byproduct profile—the major consideration—dictates suitability for further use in food, pharma, or research-grade intermediates. Inosinate salts, RNA oligonucleotides, and flavor nucleotides represent downstream product families.
Bulk and packed disodium 5'-inosine tolerate ambient storage conditions below a defined humidity threshold; elevated humidity promotes caking and hydrolysis risk. Temperature excursions above recommended range raise degradation potential, especially in high-purity and biotech grades. Light exposure does not typically affect product integrity, so dark or opaque packaging is a precaution only for specialty grades. Oxygen protection is generally not required unless demanded for ultra-pure grades or specialized blends.
Product maintains chemical stability in food-grade polyethylene, polypropylene, and fiber drums with PE liners. For pharma and biotech applications, supplier audits verify compliance of all contact polymers and confirm absence of extractable or leachable components that could alter purity or safety.
Shelf life reflects both grade and packaging method. High-purity or biotech grades, tightly sealed and humidity-controlled, have maximal shelf lives. Degradation manifests as color change, caking, or increased impurity profile; any sign triggers full quality investigation and product hold. Expiry or re-test periods stated in release documents reference validated stability programs.
Hazard identification aligns with current GHS and national regulations. Disodium 5'-inosine does not typically meet classification for acute toxicity or environmental hazard under finished product use, but this reflects regulatory review of validated toxicity data and intended handling procedures.
Normal industrial use presents low acute hazard, but routine industrial hygiene measures apply—dust generation, inhalation, and contact with eyes or mucosa can produce irritation, so closed handling and eye/face protection protocols are standard in production and packing. Spillage requires damp sweeping and avoidance of dust dispersal.
Available toxicity studies indicate low oral and dermal toxicity at typical exposure levels, but batch-specific impurity load and downstream use (e.g., pharmaceuticals, infant food) necessitate periodic review of public and proprietary toxicity reports. Occupational exposure limits for dust commonly align with general nuisance dust recommendations unless regulatory or customer-specific stricter values apply. Safe handling processes include local exhaust ventilation, personnel training, and documentation of all critical handling incidents with corrective measures.
Annual production volumes of Disodium 5'-Inosine swing along with fluctuating demand from food, pharma, and biochemical intermediates. Our teams scale output by aligning fermentation and extraction scheduling with both short-term forecasts and contract programs. Output constriction points emerge from upstream nucleoside precursor availability, reactor capacity, and site maintenance intervals. Production lines switch between food and pharmaceutical grade following rigorous cleaning validation, which introduces staggered slotting for contract customers. Inventory windows close quickly once quarterly commitments fill, so direct negotiation of forward volumes often proves essential for calendar-year stability.
Lead times vary with product grade. Food and technical grades typically dispatch within two to three weeks from order confirmation. Pharmaceutical or compendial grades, demanding more stringent batch records, often require four to five weeks owing to extended analytical release and documentation preparation. MOQ is not universally fixed; it relies on grade and packaging configuration, with food applications generally starting at half-pallet scale and pharma grades usually requiring full pallet minimums due to validation costs.
Industrial supply commonly employs multi-layer lined fiber drums ranging from 10 kg up to 50 kg net weight. Bulk requests in super sacks or intermediate bulk containers arise for higher volume users but necessitate compatibility validation due to risk of deliquescence and cross-contact. Pharmaceutical and food-grade product packaging incorporates tamper-evidence, full traceability coding, and inner polyethylene liners. Packaging material selection reflects both regulatory demands and offsite handling considerations, needing adaptation to region-specific transport constraints.
Commercial terms typically reflect incoterms such as FCA, FOB, or CIF, set by buyer geography and contract negotiation. Air and sea shipments predominate, depending on customer lead time requirements and import limitations. Payment conditions follow standard industry practice, often adopting net-30 or net-60 days for established accounts, with LC or advanced remittance for new transactions or high-value shipments. Seasonal congestion or changes in international freight regimes can drive adjustments to shipping timelines and secondary logistics costs.
Production economics for Disodium 5'-Inosine depend heavily on nucleoside precursor sourcing—as adenine, hypoxanthine, and ribose prices react to global sugar, fermentation, and solvent feedstock trends. Volatility arises from agricultural output (mainly for ribose), energy pricing, and environmental regulation shifts affecting key chemical intermediates. Fermentation yield drift, enzyme utilization rates, and solvent recapture efficiency introduce variability into batch processing costs. Each adjustment in the Chinese or Indian supply chain for core nucleoside intermediates transmits nearly directly to per-kilogram pricing.
Grade differentiation defines pricing tiers. Food and technical grades carry standard release testing and permit broader tolerance in impurity residuals, resulting in lower cost. Pharmaceutical compendial grades impose strict criteria for related nucleoside content, residual solvents, and pyrogenicity; these drive both analytical and processing overhead. Certified kosher or halal packaging, child-resistant seals, and enhanced traceability likewise introduce incremental cost based on certification outlays and production segregation. Customers specifying non-standard package sizes or requesting specialty certification cycles see a direct addition in invoicing reflective of the line change cost and certification investment required.
World demand for Disodium 5'-Inosine pivots around processed foods (flavor enhancement), injectable pharmaceuticals (energy metabolism modulator), and molecular biology. Supply concentration remains weighted toward East Asia, especially China and Japan, due to integration of nucleoside raw material plants and downstream processing clusters. Shortages trace back to feedstock interruptions or regulatory-driven production quotas, as seen intermittently in China’s controlled zones. Europe, North America, and Japan depend on imports for specialty and pharmaceutical grades, with local blending sometimes used for food-grade products.
Cost projection for 2026 will depend on continued unpredictability in upstream fermentation capacity, regulatory interventions in Chinese supply, and an ongoing shift toward sustainability in feedstock sourcing. Customers requiring pharmaceutical or specialty grades may see moderate year-on-year price pressure as compliance burdens intensify. Bulk food and technical grades should remain price-competitive as capacity expands, though risk from environmental compliance actions and energy cost spikes remains high.
Trend analysis relies on longitudinal review of industry survey data, import/export records, and quarterly procurement benchmarks from established users in food and pharma. Manufacturer-side input focuses on batch production statistics, quality control analytics, and supply chain audits. Market intelligence is periodically updated against external shocks in fermentation substrate markets and transport regulation change.
Recent changes in environmental policy enforcement in major producing regions have shortened output windows and extended batch validation intervals. Observed volatility in nucleoside precursor markets correlates with both regulatory actions and seasonal agricultural feedstock availability. Several international buyers shifted multi-year contracts toward shorter durations in response to these variables, seeking more adaptable price adjustment mechanisms.
Ongoing harmonization of food contact, pharmaceutical, and biochemical certification standards periodically introduces new documentation layers. Batch segregation, enhanced impurity profiling, and increased scrutiny on residual solvent and heavy metal content have altered both cost base and batch release protocol. Recent global moves toward environmental accountability accelerate internal process audits, raising compliance cost for both exporters and major importers alike.
Manufacturers expand direct collaboration with qualified feedstock producers, invest in solvent recapture upgrades, and deploy advanced impurity profiling methods to maintain product reliability. Larger producers commit to internal certification auditors and invest in multi-product validation to reduce process downtime during grade transitions. Production sites synchronize document management systems with changing international requirements and maintain agile inventory buffers to address supply chain interruptions.
Disodium 5'-Inosine, produced in our dedicated nucleotide facility, serves diverse roles across several mature industries. These applications span food ingredients, biopharma production, research reagents, and specialty fine chemicals. In the food sector, the product functions as a flavor enhancer or nucleotide supplement. The formulation and regulatory grade differ from those designated for pharmaceutical and biotech uses, where stricter impurity thresholds and batch-to-batch consistency often drive specifications.
In cell culture media and diagnostics, demand for ultra-high purity dominates sourcing decisions, as residual contaminants can directly affect downstream assay performance. For bioprocess manufacturing and custom synthesis, customers may request tailored grades to meet application-specific requirements, especially where downstream purification is not expected to remove residual inorganic salts or organic impurities.
| Typical Application | Recommended Grade | Rationale |
|---|---|---|
| Food Flavor Enhancement | Food Grade | Meets food additive regulatory standards, focus on microbial and heavy metal control. |
| Cell Culture & Media | Ultra-Pure (Biotech) Grade | Requires lowest bioburden, endotoxin control, and transparency on animal-origin-free status. |
| Pharmaceutical Intermediates | Pharma or Custom Refined Grade | Impurity profile and documentation defined by final drug master file or local agency requirements. |
| Analytical & Laboratory Use | Analytical/Research Grade | Focus on trace impurities and documentation for reproducibility. |
Quality control criteria shift based on application and region. Food customers often prioritize compliance with food-grade additive lists and certification of absence of allergens or restricted contaminants. Biotech customers look closely at total organic carbon, heavy metal traces, nucleic acid residuals, DNAse/RNAse activity, and sterile filtration documentation. Pharmaceutical clients require a defined impurity spectrum with transparent change control for specification boundaries, and certification of conformance to compendial monographs where applicable.
Production teams must adjust raw material audits and process validation depending on the grade targeted, including solvent quality, filter selection, and cross-contamination controls in the plant to avoid grade mixing.
Begin by clearly identifying the intended industry use. The suitability of a batch varies for food, biotech, or pharma due to differences in quality and regulatory expectations. Providing this information to the manufacturer at the inquiry stage speeds up technical recommendation and processing.
Check local and target-market regulations for maximum allowable impurity levels, acceptable process aids, allergen status, and animal-origin statements. Vendors must declare compliance to these expectations; document collection at this stage prevents downstream rejections or audit failures.
Purity requirements depend entirely on application. For analytical or diagnostic settings, total impurities and specific trace elements can determine the outcome of testing protocols. Pharma manufacturing typically requires ongoing monitoring of both known process impurities and potential cross-species nucleic acids.
Production economics tie directly to minimum batch size availability by grade. Lab-scale applications may favor higher purity in smaller packs, at a higher per-unit cost. Industrial-scale users often prioritize price per kilogram, but must balance this against the risk of specifying a non-conforming batch if they select a lower grade than application or region permits.
Validation support is critical for grade selection. The technical team checks compatibility with downstream formulation steps, stability under actual plant or lab storage, and integrity under shipment. Sample trials also reveal issues with solubility, discoloration, or reactivity that could affect process efficiency. QC staff document and trend trial data to support full-scale batch ordering.
At our production site, quality management certifications are maintained to address both domestic and international procurement standards. Our factory adheres to systems such as ISO-based quality management, which structure the manufacturing process from raw material approval to batch release. Audits occur regularly, driven by requirements from both internal protocols and customer compliance checks. Key operational records cover the full production traceability chain: batch material flow, reactor cleaning details, cross-contamination prevention steps, as well as change and deviation management. Certification renewal cycles synchronize with ongoing process changes, ensuring documentation reflects current practice instead of static procedural snapshots.
Disodium 5'-Inosine certification requirements often shift depending on the target application sector and customer audit findings. For food or pharmaceutical grades, compliance may encompass regionally recognized food additive or pharmacopeia standards, depending on end-market destination. Verification of product-specific certificates references both in-house analysis results and third-party validated reports. Country of origin declarations, allergen statements, and GMO-free confirmations align with request-driven documentation cycles. Changes in regulatory status or updates to compendia specifications prompt a re-examination of relevant documents, with results distributed to contracted buyers.
The documentation package for each consignment of Disodium 5'-Inosine includes batch-specific COAs, analytical test summaries, impurity profiling, and—when specified—microbial and residual solvent assessments. Data sources cover both production analytics and downstream packing inspections, with archiving ensuring reproducibility for multi-year recall. Traceability begins with incoming raw material lot assignment, tracked through batch processing records and extending to post-release logistics documents. Tailoring report content to grade, process route, or customer requirement is common, especially for end users who mandate periodic method revisions or supplemental data entries not covered by standard QC sheets.
Our primary production capacity for Disodium 5'-Inosine is modeled on a base-load production plan, covering contract volume and allowing for unplanned demand. Capacity is verified against utility headroom, available reactor cycles, and supplier raw material lead times. For partners needing flexible shipment cycles, the business team coordinates batch scheduling with production planners, balancing between fixed-term contracts and spot order adjustment windows. Fluctuations in market demand or raw material availability are managed by adjusting stock buffers and lead times, rather than promising rigid guaranteed output regardless of input changes.
Core process capacity derives from long-term equipment allocation and supplier qualification. Critical production bottlenecks—such as chromatography bed lifetime and crystallizer washout frequency—receive focused monitoring during campaign production runs. Stability in supply is achieved through rapid in-process quality checks, batch-to-batch comparison monitoring, and finished goods inventory rotation. For export customers, route-specific documentation and transport handling instructions accompany each consignment, reflecting destination-specific regulations and customer protocols rather than one-size-fits-all workflows.
Sample dispatch follows a cross-departmental request-and-approval cycle. QC and production teams select representative samples according to lot release schedules, with batch information provided to ensure traceability and performance consistency in customer trials. For special evaluation requests, customized documentation and additional analytical datasets can be supplied, based on project or application needs. Chain-of-custody is maintained through both internal records and outbound logistics confirmations. The sample process may vary if target applications require deviation from standard grades or necessitate special handling, temperature control, or short shelf-life management.
Flexible business models depend on the customer’s offtake pattern, sector-specific needs, and region-specific import requirements. Annual volume contracts, rolling forecast agreements, and spot-purchase allocations are all structured differently, with procurement lead time, payment terms, and delivery frequency coordinated to support buyer inventory objectives. In periods of raw material volatility, allocation policies are communicated transparently to customers with active contracts. Dedicated technical support for formulation changes, impurity profile discussions, and documentation customizations integrates directly with the sales cooperation cycle, ensuring operational alignment across both sides of the partnership.
Within our R&D teams, the drive centers on streamlining synthetic routes and fine-tuning product purity for food/pharma-grade disodium 5'-inosine. Several groups focus on optimizing enzymatic and fermentation-based production, shifting away from traditional chemical synthesis to improve yield and reduce by-product formation.
Impurity profiles receive close attention. Industrial production routes can introduce site-specific by-products, such as sodium salt variants or unconverted nucleotide fractions, which impact the sensory and functional properties in food applications. Addressing these requires layered control along the purification and crystallization stages. Each adjustment, such as pH modulation, solvent selection, or seed loading, can move the product specification toward desired application-specific targets.
Market observations reveal new applications beyond core areas such as savory ingredient compounding and pharmaceutical excipients. There is active exploration within the animal nutrition sector, where nucleotide supplementation can influence livestock growth and immunity. Research groups are also assessing synergistic combinations with other nucleotides in specialty diets, as well as prospects in biopharmaceutical fermentation media where the compound influences cell growth profiles.
Scaling up enzymatic and fermentation-based manufacturing continues to pose reproducibility and downstream separation challenges. Consistency in feedstock and biocatalyst performance holds significant sway over batch yields and impurity carryover. Recent breakthroughs include real-time feed monitoring, automated pH-stat bioreactors, and advanced membrane filtration for purification. Some installations integrate online HPLC analysis to ensure tighter conformity to grade allocations during processing.
Forecasting over the next three to five years, incremental demand is expected from the flavor enhancement and nutraceutical segments in East Asia and North America, with niche growth in clinical nutrition. Supply expansion in regions with advanced biotech parks will intensify price competition, especially for food-grade and feed-grade material. Buyers increasingly weigh not only price per kilogram but documentation supporting heavy-metal content, traceability, and validation of feedstock origin.
Technology roadmaps point toward integrated biosynthetic and hybrid routes, emphasizing resource utilization and lower energy intensity. Adoption of continuous processing and closed-loop solvent recovery contributes directly to improved environmental footprint and cost structure. New process analytic technologies, such as inline spectroscopy and digital batch release triggers, further support compliance with global food and pharma standards, particularly in regulated export markets.
There is ongoing scrutiny over waste stream management and solvent usage. For disodium 5'-inosine, process modifications that minimize salt waste, recover mother liquors, and utilize bio-based raw materials are under active evaluation. Internal project teams benchmark carbon intensity per ton produced, and several partners now request life-cycle impact documentation as part of qualification procedures. The push toward green chemistry hinges on both regulatory drivers and brand-led requirements in high-visibility end-use segments.
Our technical service engineers routinely provide support on grade selection, impurity profile analysis, and process mapping for downstream integration. Application-specific consultation helps end users understand the impact of different grades on final product functionality, panel test results, and process stability.
Collaborative trials with customer formulation teams enable optimization of dosing, pre-blending techniques, and interaction with co-ingredients. For food applications, our specialists provide solubility and sensory stability data relevant to the customer’s matrix. In pharmaceutical use, detailed impurity mapping and compliance dossiers support registration and regulatory submissions.
Our support extends through root-cause investigation in the event of unexpected results downstream, including batch reanalysis and traceability audits. Batch consistency is controlled by multi-point analytical verification, with the release criteria defined by both internal protocols and customer-agreed standards. All product shipments include a certificate of analysis specifying controlled attribute ranges; additional release documentation is available based on the contract or market entry requirements.
Producing Disodium 5'-Inosine requires precise control over raw materials and reaction conditions. Our plant handles every stage, from material sourcing to purification and drying. We operate with a closed-loop process, which helps maintain traceability and performance batch to batch. Raw inosine undergoes phosphorylation and subsequent sodium neutralization, using high-grade reagents to limit unwanted byproducts. Continuous on-site monitoring at each stage gives us confidence before moving on to the next step.
Disodium 5'-Inosine serves as a nucleic acid flavor enhancer. It finds principal use in prepared foods, stock powders, and snack manufacturing. Major seasoning and soup producers integrate it at scale, given its reliable salt-enhancing properties and compatibility with automated batching lines. Pharmaceutical formulators turn to our processed grade to support specific compositions where nucleotides are required. Fermentation companies incorporate this compound during microbial culture development, responding to consistent ingredient performance.
Every production run follows defined sampling and analytical routines. High-performance liquid chromatography checks purity, and lab technicians confirm sodium content and pH. We review trends by lot and take corrective action if readings shift outside the permitted range. Equipment is calibrated and maintained under a documented internal schedule. Certificates of analysis accompany all shipments, giving buyers full transparency for downstream regulatory file compliance or food safety audits. Our team documents lot genealogy as part of our commitment to verifiable traceability. External audits by third parties are welcomed as needed by clients with stricter requirement sets.
Large-scale filling lines support both bulk and downstream packing. We offer bag-in-fiber drum, palletized kraft bags, and customized sizes for integration into production environments with space constraints. All packaging takes place in a closed atmosphere to limit contamination risk. Raw material intake, product transport, and shipment dispatch are monitored in real time to safeguard against disruption. Supply agreements allow for call-off deliveries and safety stock warehousing on behalf of repeat industrial customers. Regional logistics partners work directly with our shipping managers, not through middle channels, to coordinate optimal scheduling and handle post-shipment documentation.
Our technical team fields inquiries directly from process engineers and R&D managers at client sites. Troubleshooting covers mixing, dissolution, dosage adjustment, and compliance clarification. During new product introductions, specialists share application experience related to Disodium 5'-Inosine’s solubility and flavor profile under varying process conditions. If a specification change occurs, our staff evaluates the modification in the lab before introducing it into regular production—no shortcuts or handoffs. We maintain documentation for regulatory submissions and support partner audits as part of our standard offer.
Engaging directly with a production site means procurement managers access up-to-date supply status and lead time indicators without relying on third-party communication. Quality assurance officers obtain direct access to production records, technical literature, and compliance data sets for routine or project-specific validation. Distributors and industrial users benefit from reduced risk through secured contractual obligations, rather than uncertain spot buying. Cost planning improves when working factory-direct, with aligned forecasts, buffer stock discussions, and long-term agreement frameworks. Our company delivers more than inventory; we deliver direct production experience and accountability to every partner in the value chain.
Within our production facility, every batch of Disodium 5'-Inosine receives scrutiny long before it ships for food use, and questions about purity specifications and testing methods come up from customers across industries. It’s not just a box-ticking exercise — this is foundational for quality, especially in food. Food manufacturers require confidence in both the ingredient’s consistency and the transparency of the test methods.
Food standards across the globe set a high bar for nucleotides like Disodium 5'-Inosine. Most markets reference the Joint FAO/WHO Expert Committee on Food Additives (JECFA) or use equivalents drawn up by national authorities. We set our minimum purity at not less than 98% on a dried basis. That number isn’t just theoretical: we’re talking about actual material content after deducting moisture and any inorganic residue (usually expressed as ash).
Reaching that purity consistently demands repeated crystallization and precise pH adjustments during processing. The raw materials we use—inosine monophosphate and sodium hydroxide—both need thorough upstream qualification. Any inconsistency in upstream fermentation or hydrolysis will immediately show up in the nucleoside composition and affect the end purity. Our process also targets residual heavy metals and related substances. By monitoring critical control points, we drive out impurities so that food processors don’t have to worry about off-flavors or regulatory compliance headaches down the line.
For the assay, we rely squarely on high performance liquid chromatography (HPLC). Colorimetric tests served the industry in earlier years, but HPLC is the method that allows us to dissect the nucleotide profile across dozens of lots per week. In our hands, HPLC separates and quantifies Disodium 5'-Inosine from structurally similar compounds, including other nucleotides and residual starting materials. The instrument output doesn’t just give a total sum, it shows any minor peaks that would suggest unreacted substrate, byproducts, or contamination from equipment.
We run standards in parallel for every production batch. This lets us compare retention times and peak intensity so customers receive certificates of analysis with clear, traceable results. It also means we catch minor issues early without disruptions to our partners’ production lines.
Most of our food-grade customers push for consistent material that meets published monographs and lines up with regulatory filings. With rising expectations among international food brands, it’s not enough to deliver a chemical that just falls inside a minimum range. Manufacturers on our side of the industry put in the work to document origin, control microbials, and fully validate both the process and the analytics. Our technical support documents the full spectrum of tests — not just purity and assay, but also moisture, pH, loss on drying, and heavy metals every time.
No shortcuts in batch release: every shipment comes from monitored processes, and every lot’s data package stays accessible for years. If customers have particular requirements, we work with technical and QA teams on specifics, adjusting documentation or analytical reports as needed. The whole system is built to support confidence in ingredient safety, traceability, and performance, right from fermentation through to finished food applications.
We manufacture Disodium 5'-Inosine with a deep understanding of global bulk ingredient supply. Our standard minimum order quantity reflects the realities of full-scale chemical synthesis, raw material throughput, and international logistics. A MOQ of 500 kilograms is the current norm in our operation. This batch size ensures each production run achieves solid process efficiency and lot integrity, balancing plant utilization and order flexibility. Such a minimum allows us to deploy our full QA/QC protocol on each batch, using validated in-house methods and routine third-party checks.
Lower quantities like 100 or 200 kilograms often result in inefficient use of reactor volume, increased cleaning cycles, and added cost per kilo. Large-scale formulators in food, pharma, or biotech typically find our MOQ aligns with monthly or quarterly demand. Our technical team works closely with procurement managers who want an uninterrupted supply chain and consistent product profile. Maintaining this MOQ also allows for easier scheduling of each batch and supports proper segregation of grades or special formulations on request.
Lead time starts with firming up a PO and confirming technical details such as particle size or packaging. In most cases, typical lead time for Disodium 5'-Inosine is 3 to 4 weeks ex-works. That includes slotting your production in our monthly schedule, securing and verifying each raw input, and running the batch under controlled conditions. Each run undergoes repeated sampling and in-house QC before we package the final product—either in fiber drums or multi-layer bags, depending on customer requirement.
Factors affecting lead time include current factory load, material inbound times, and any custom requirements. During periods of volatile raw material pricing or transport delays—such as during global supply chain disruptions—lead times can shift. Our plant team monitors upstream and downstream logistics daily and communicates expected deviations as soon as possible. We don’t commit to unrealistic ex-stock promises; every PO is tracked by both our production office and export documentation desk from start to finish.
Our decision-making draws on repeated process qualification, historical QC data, and inventory management. Too small a batch leads to disproportionate fixed costs, variable output, and higher risk of cross-contamination. Maintaining our MOQ provides a foundation for serialized production records, scalable delivery, and regulatory document preparation—often required by major food and pharmaceutical clients. Oversized batches, unless pre-negotiated in frame contracts, could disrupt downstream manufacturing.
Our global clients rely on predictable delivery, especially when coordinating multi-country product launches or just-in-time warehousing. We employ cloud-based order tracking, with updates from the packing floor to outgoing container, to underpin reliability. Flexibility can be engineered through early planning: larger annual commitments may allow for staggered dispatch, and our technical service team is always available to anticipate needs and manage supply risk on high-sensitivity projects.
Continuous investment in new process equipment and warehouse automation lets us keep these commitments transparent and grounded in the actual flow of goods through our plant. All processes remain open to audit and verification by customers looking for a true manufacturer’s perspective.
Manufacturing Disodium 5'-Inosine for food use requires a focused approach to regulatory compliance. Our quality assurance, production, and regulatory teams work together to ensure every batch follows the relevant legislation for food additives in both the European Union and the United States. We track the latest changes under Regulation (EC) No 1333/2008, which governs food additives in the EU, and the FDA’s CFR Title 21, which covers food additives status and labelling in the US. Our process starts with sourcing traceable raw materials, developing transparent production records, and running complete analytical testing.
Each order ships with a full Certificate of Analysis (COA) that records batch number, production date, testing data, and conformity to purity levels, lead and heavy metals limits, and microbiological standards specified in key regulatory frameworks. These documents confirm our Disodium 5'-Inosine meets the purity and safety mandates set by the FDA and EFSA for use as a flavour enhancer (E631). COAs draw from our validated methods, analytical logs, and up-to-date regulatory files.
Traceability documentation is available for every stage of manufacturing — from raw nucleotides and reagents, through blending and granulation, to finished product. Our production system records lot numbers, supplier certifications, and processing parameters. This trace-back capability supports audits and makes sure we provide a transparent supply chain at every step. Our technical archive holds specifications, flow charts, and safety data to meet customer, regulatory, or audit inquiries.
We pay close attention to updates from EFSA and the FDA. If there is a change in residual solvent tolerance or authorised usage rates, our compliance unit adapts our protocols immediately. Our team regularly participates in industry forums and exchanges with regulatory agencies. This helps us adjust manufacturing controls and documentation in real time, so customers receive product that is always in line with the most current food safety rules.
In the US, Disodium 5'-Inosine is authorised as a flavour enhancer, subject to limitations on good manufacturing practice and certain purity criteria. In the EU, the same additive is only permitted in specific food categories, and under explicit labelling. Because ingredient status can change as standards evolve, we rely on continual monitoring, internal training, and a dedicated regulatory desk to review the legal position for every shipment. Our approach always aims for proactive compliance.
We understand brand owners, food processors, and global supply managers require detailed evidence for both regulatory and quality assurance programs. Our support includes not only COA and specification sheets, but also all relevant traceability and manufacturing data. We regularly host customer and third-party audits in our facilities, demonstrating data integrity and transparency across procurement, processing, and packaging. Digital documentation is available for major food safety management systems when required.
We take responsibility for both product safety and legal conformity. As the direct manufacturer, we make sure our customers can confidently incorporate our Disodium 5'-Inosine into foods destined for any market governed by EU or US law, with reliable support for every batch.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
